-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Evolent Health, Lowers Price Target to $10

Benzinga·01/06/2026 12:55:27
Listen to the news
Citizens analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and lowers the price target from $11 to $10.